
    
      Acute and chronic improvement of endothelial function is expected through the pleiotropic
      effect of DPP-4 inhibitors. A randomized, prospective, open-labeled, parallel design. The
      duration of treatments with sitagliptin or glimepiride is 12 weeks. The number of study
      centers is a single (Dokkyo Medical University Hospital). Participants will be randomized
      into the two treatment groups; (a) 50mg sitagliptin (N=15) and (b) 1mg glimepiride (N=15).

      Anti-Hyperglycemic effect is expected to be similar according to our study
    
  